Norris Cotton Cancer Center
About Us News & Events Careers How to Help
Patient Care For Patients & Visitors For Cancer Professionals Cancer Research Clinical Trials Regional Locations
Search

Vivek Samnotra MD

Contact Information:
Phone: (603) 335-8490
Fax: (603) 335-8475
Email: not given

Institution Affiliations:
Medical Director, Center for Cancer Care at Frisbie Memorial Hospital
Assistant Professor of Medicine (Hematology/Oncology)
Department of: MEDICINE
Section: Hematology/Oncology
Specialty: Medical Oncology
Joined Staff: 2001

Cancer Center Membership:
Section of Hematology / Oncology
Genitourinary / Prostate Oncology Program
Endocrine Tumors Oncology Program

Clinical Interests:
A Phase II Trial of ZD1839 (Iressa®) in Patients with Nonresectable Adrenocortical Carcinoma (ACC)
Prostate Cancer
Adrenal Cancer
Board Certified:
Medical Oncology 1997
Internal Medicine 1996
Degree(s): MD
McGill University, Montreal, PQ, Canada 1989

Internship(s):

Residency:
University of Pittsburgh, Montefiore Hospital, Pittsburgh, PA, (Internal Medicine) 1989-91
Tufts University, St. Elizabeth's Hospital, Boston, MA, (Internal Medicine) 1991-93

Fellowship(s):
National Cancer Institute, National Institutes of Health, Bethesda, MD, (Medical Oncology) 1993-96

Biography:
Dr. Samnotra received his BA in 1985 from Johns Hopkins University and his MD in 1989 from McGill University. He completed an internship in 1991 from Montefiore Hospital and in 1993 he completed his residency from St. Elizabeth's Hospital. Dr. Samnotra did his Hematology/Oncology fellowship at the National Institutes of Health. From 1996 to 1997 Dr. Samnotra worked as a Locum Tenens and from 1997 to 1998 he was staff oncologist at the Comprehensive Cancer Care Specialists in Boca Raton, Florida followed by another period of Locum Tenens work from January 1999 to April 1999. In May 1999 he became staff oncologist at the Saint Vincent Hospital, University of Massachusetts, and in July 2001 he joined the DHMC affiliate Frisbie Memorial Hospital as staff oncologist.

Research Interests:
A Phase II Trial of ZD1839 (Iressa®) in Patients with Nonresectable Adrenocortical Carcinoma (ACC)
Development of clinical trials (both Phase I and Phase II)

Selected Publications:
Samnotra V, Robey PG, Stetler-Stevenson WG. Osteoblastic cells produce chemotactants that specifically stimulate motility of invasive prostate cancer cell lines. In press 2002.
Samnotra V, Germinario RJ, Wainberg MA. Presence of insulin binding sites on viral particles. Antiviral Research, 1998;9:285-293.
  

NCI Logo